MRI detects breast cancer in the contralateral breast for postmenopausal women better than a clinical or mammographic examination, according to a Mayo Clinic study published in the March/April The Breast Journal.
MRI detects breast cancer in the contralateral breast for postmenopausal women better than a clinical or mammographic examination, according to a Mayo Clinic study published in the March/April The Breast Journal.
The researchers found 16 of 425 women, all postmenopausal, had breast cancer in the undiagnosed breast. Furthermore, patients 70 and older had a higher prevalence of cancer detected in the second breast than their younger counterparts. MRI found a cancer in seven of the 129 women 70 and older. Mammography and clinical examination did not detect cancer in any of the contralateral breasts.
“Elderly women in good health potentially benefit from earlier detection, and we believe that screening the undiagnosed breast with MRI should be considered in all postmenopausal women diagnosed with a breast cancer,” said lead investigator Dr. Johnny Ray Bernard Jr., a radiation oncologist at the Mayo Clinic in Jacksonville, FL.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.